Failure pattern and salvage treatment after radical treatment of head and neck cancer

References

• Johansen LV, Grau C, Overgaard J. Glottic carcinoma-patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol 2002;63:257–267.
   PubMed Web of Science ®Google Scholar
• Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma-treatment results in 138 consecutively admitted patients.. Acta Oncol 2000;39:529–536.
   PubMed Web of Science ®Google Scholar
• Goodwin WJ. Jr., Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000;110:1–18.
   PubMed Web of Science ®Google Scholar
• Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun RJ, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 2008;26:5518–5523.
   PubMed Web of Science ®Google Scholar
• Jung YH, Song CM, Park JH, Kim H, Cha W, Hah JH, et al. Efficacy of current regular follow-up policy after treatment for head and neck cancer: need for individualized and obligatory follow-up strategy. Head Neck 2014;36:715–721.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933–940.
   PubMed Web of Science ®Google Scholar
• Pagh A, Vedtofte T, Lynggaard CD, Rubek N, Lonka M, Johansen J, et al. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA. Acta Oncol 2013;52:277–284.
   PubMed Web of Science ®Google Scholar
• Pagh A, Grau C, Overgaard J. A longitudinal study of follow-up activities after curative treatment for head and neck cancer. Acta Oncol 2015;54:813–819.
   PubMed Web of Science ®Google Scholar
• Bjørndal K, Krogdahl A, Therkildsen MH, Overgaard J, Johansen J, Kristensen CA, et al. Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 2011;47:677–682.
   PubMed Web of Science ®Google Scholar
• Bentzen J, Toustrup K, Eriksen JG, Primdahl H, Andersen LJ, Overgaard J. Locally advanced Head and Neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatinum. Results from the Dahanca 18 phase II study. Acta Oncol 2015;54:1001–1007.
   PubMed Web of Science ®Google Scholar
• Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426–430.
   PubMed Web of Science ®Google Scholar
• Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 2001;258:177–183.
   PubMed Web of Science ®Google Scholar
• Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG. Decision making in the management of recurrent head and neck cancer. Head Neck 2014;36:144–151.
   PubMed Web of Science ®Google Scholar
• Gleich LL, Ryzenman J, Gluckman JL, Wilson KM, Barrett WL, Redmond KP. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg 2004;130:35–38.
   PubMedGoogle Scholar
• Omura G, Saito Y, Ando M, Kobayashi K, Ebihara Y, Yamasoba T, et al. Salvage surgery for local residual or recurrent pharyngeal cancer after radiotherapy or chemoradiotherapy. Laryngoscope 2014;124: 2075–2080.
   PubMed Web of Science ®Google Scholar
• Flynn CJ, Khaouam N, Gardner S, Higgins K, Enepekides D, Balogh J, et al. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer. Clin Oncol (R Coll Radiol) 2010;22:868–873.
   PubMed Web of Science ®Google Scholar
• Cooney TR, Poulsen MG. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg 1999;125:379–382.
   PubMedGoogle Scholar
• Huang SH, Perez-Ordonez B, Weinreb I, Hope A, Massey C, Waldron JN, et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol 2013;49:79–85.
   PubMed Web of Science ®Google Scholar
• Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced orophaynx and non-oropharynx cancer. Radiother Oncol 2014;113:310–316.
   PubMed Web of Science ®Google Scholar
• Pivot X, Niyikiza C, Poissonnet G, Dassonville O, Bensadoun RJ, Guardiola E, et al. Clinical prognostic factors for patients with recurrent head and neck cancer: implications for randomized trials. Oncology 2001;61:197–204.
   PubMed Web of Science ®Google Scholar
• Zafereo M. Surgical salvage of recurrent cancer of the head and neck. Curr Oncol Rep 2014;16:386–014. 0386-0.
   PubMed Web of Science ®Google Scholar
• Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM, Lewin JS, Roberts DB, et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 2009;115:5723–5733.
   PubMed Web of Science ®Google Scholar
• Lilja-Fischer JK, Jensen K, Eskildsen HW, Fink-Jensen V, Nielsen VE. Response evaluation of the neck in oropharyngeal cancer: value of magnetic resonance imaging and influence of p16 in selecting patients for post-radiotherapy neck dissection. Acta Oncol 2015;54:1599–1606.
   PubMed Web of Science ®Google Scholar
• de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 1994;120:934–939.
   PubMedGoogle Scholar
• Manikantan K, Dwivedi RC, Sayed SI, Pathak KA, Kazi R. Current concepts of surveillance and its significance in head and neck cancer. Ann R Coll Surg Engl 2011;93:576–582.
   PubMed Web of Science ®Google Scholar
• Lyhne NM, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, et al. The DAHANCA 6 randomized trial: effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma. Radiother Oncol 2015;117:91–98.
   PubMed Web of Science ®Google Scholar
• Taki S, Homma A, Oridate N, Suzuki S, Suzuki F, Sakashita T, et al. Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients. Eur Arch Otorhinolaryngol 2010;267:1765–1769.
   PubMed Web of Science ®Google Scholar
• Patel SN, Cohen MA, Givi B, Dixon BJ, Gilbert RW, Gullane PJ, et al. Salvage surgery for locally recurrent oropharyngeal cancer. Head Neck 2015; (E-pub ahead of print) doi: 10.1002/hed.24065.
   Web of Science ®Google Scholar
• Arnold DJ, Goodwin WJ, Weed DT, Civantos FJ. Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck. Semin Radiat Oncol 2004;14:190–195.
   PubMed Web of Science ®Google Scholar
• Wong SJ, Machtay M, Li Y. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 2006;24:2653–2658.
   PubMed Web of Science ®Google Scholar